Related Experiment Videos
[The current status and future applications of gene therapy and immunogene therapy for malignant lymphoma]
Abstract:
The present therapy for malignant lymphoma including stem cell transplantation, has been greatly developed. However, treatments still remain ineffective for many patients. Gene therapy is providing new strategies for the treatments of malignant lymphoma. There are three major approaches; 1) killing the tumor cell itself by introducing anti-sense genes against oncogene, tumor suppressor genes or drug-sensitive genes. 2) modifying the immune response by introducing genes that will trigger anti-tumor response or tumor specific genes to antigen presenting cell. 3) decreasing the sensitivity of hemopoietic cells by introducing drug resistance genes. We describe here the current and future applications of gene therapy for malignant lymphoma.
Insights
Gene therapy offers new strategies for malignant lymphoma treatment. Approaches include directly killing cancer cells, enhancing anti-tumor immune responses, and increasing drug resistance in hemopoietic cells.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Context:
- Malignant lymphoma treatments, including stem cell transplantation, have advanced but remain ineffective for many patients.
- Gene therapy presents novel therapeutic avenues for malignant lymphoma.
- Current treatment limitations necessitate exploration of innovative strategies.
Purpose:
- To review the current and future applications of gene therapy in treating malignant lymphoma.
- To outline the primary gene therapy approaches for malignant lymphoma.
- To highlight the potential of gene therapy to overcome treatment resistance.
Summary:
- Gene therapy for malignant lymphoma involves three main strategies: introducing anti-sense genes to target oncogenes or tumor suppressor genes, modifying immune responses by introducing genes for anti-tumor activity or antigen presentation, and enhancing drug resistance in hemopoietic cells.
- These approaches aim to directly eliminate tumor cells, stimulate an anti-cancer immune response, or protect healthy cells during treatment.
- The review covers existing and potential future uses of these gene-based interventions.
Impact:
- Gene therapy holds significant promise for improving outcomes in malignant lymphoma patients.
- This approach could lead to more effective and targeted treatments with potentially fewer side effects.
- Advancements in gene therapy may offer new hope for refractory or relapsed lymphoma cases.